News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
756,050 Results
Type
Article (47825)
Company Profile (507)
Press Release (707705)
Multimedia
Podcasts (130)
Webinars (20)
Section
Business (212377)
Career Advice (2175)
Deals (37535)
Drug Delivery (127)
Drug Development (84615)
Employer Resources (177)
FDA (16992)
Job Trends (15538)
News (360354)
Policy (34246)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2755)
Academic (1)
Accelerated approval (40)
Adcomms (29)
Allergies (154)
Alliances (52194)
ALS (186)
Alzheimer's disease (1760)
Antibody-drug conjugate (ADC) (351)
Approvals (17234)
Artificial intelligence (615)
Autoimmune disease (173)
Automation (46)
Bankruptcy (385)
Best Places to Work (11978)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (351)
Bladder cancer (169)
Brain cancer (65)
Breast cancer (672)
Cancer (5142)
Cardiovascular disease (440)
Career advice (1844)
Career pathing (41)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (38)
Clinical research (72034)
Collaboration (1887)
Company closure (4)
Compensation (1207)
Complete response letters (69)
COVID-19 (2836)
CRISPR (105)
C-suite (926)
Cystic fibrosis (153)
Data (6549)
Decentralized trials (2)
Denatured (42)
Depression (150)
Diabetes (521)
Diagnostics (7005)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (305)
Drug pricing (202)
Drug shortages (30)
Duchenne muscular dystrophy (255)
Earnings (92388)
Editorial (64)
Employer branding (21)
Employer resources (157)
Events (122654)
Executive appointments (1036)
FDA (20264)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1586)
Gene editing (226)
Generative AI (54)
Gene therapy (680)
GLP-1 (1057)
Government (4893)
Grass and pollen (6)
Guidances (386)
Healthcare (19537)
HIV (74)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (285)
Immuno-oncology (71)
Indications (128)
Infectious disease (3130)
Inflammatory bowel disease (210)
Inflation Reduction Act (17)
Influenza (127)
Intellectual property (264)
Interviews (344)
IPO (17074)
IRA (54)
Job creations (3924)
Job search strategy (1535)
JPM (67)
Kidney cancer (18)
Labor market (87)
Layoffs (601)
Leadership (37)
Legal (8337)
Liver cancer (94)
Longevity (17)
Lung cancer (695)
Lymphoma (390)
Machine learning (46)
Management (61)
Manufacturing (863)
MASH (175)
Medical device (14176)
Medtech (14237)
Mergers & acquisitions (21570)
Metabolic disorders (1371)
mRNA (187)
Multiple sclerosis (173)
NASH (19)
Neurodegenerative disease (359)
Neuropsychiatric disorders (102)
Neuroscience (3118)
Neurotech (1)
NextGen: Class of 2026 (6914)
Non-profit (4700)
Now hiring (69)
Obesity (659)
Opinion (305)
Ovarian cancer (171)
Pain (212)
Pancreatic cancer (247)
Parkinson's disease (308)
Partnered (35)
Patents (527)
Patient recruitment (536)
Peanut (61)
People (61293)
Pharmaceutical (91)
Pharmacy benefit managers (32)
Phase 1 (22640)
Phase 2 (31713)
Phase 3 (23496)
Pipeline (5880)
Policy (314)
Postmarket research (2655)
Preclinical (9753)
Press Release (70)
Prostate cancer (263)
Psychedelics (56)
Radiopharmaceuticals (310)
Rare diseases (952)
Real estate (6330)
Recruiting (71)
Regulatory (25750)
Reports (55)
Research institute (2567)
Resumes & cover letters (371)
Rett syndrome (29)
RNA editing (21)
RSV (83)
Schizophrenia (162)
Series A (268)
Series B (204)
Service/supplier (12)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3882)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (85)
The Weekly (86)
Vaccines (1070)
Venture capital (97)
Weight loss (431)
Women's health (101)
Worklife (20)
Date
Last 7 days (904)
Last 30 days (2738)
Last 365 days (31169)
2026 (5063)
2025 (31768)
2024 (36803)
2023 (41341)
2022 (52616)
2021 (57171)
2020 (55592)
2019 (48262)
2018 (36377)
2017 (33728)
2016 (33233)
2015 (39218)
2014 (33105)
2013 (28171)
2012 (30174)
2011 (30790)
2010 (28971)
Location
Africa (805)
Alabama (92)
Alaska (7)
Arizona (327)
Arkansas (15)
Asia (42306)
Australia (7015)
California (11907)
Canada (3395)
China (1173)
Colorado (498)
Connecticut (511)
Delaware (346)
Europe (93132)
Florida (1762)
Georgia (378)
Hawaii (3)
Idaho (64)
Illinois (920)
India (71)
Indiana (547)
Iowa (24)
Japan (451)
Kansas (131)
Kentucky (45)
Louisiana (28)
Maine (72)
Maryland (1448)
Massachusetts (8641)
Michigan (342)
Minnesota (652)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (29)
Nevada (128)
New Hampshire (87)
New Jersey (3161)
New Mexico (32)
New York (3127)
North Carolina (1584)
North Dakota (9)
Northern California (5808)
Ohio (358)
Oklahoma (21)
Oregon (46)
Pennsylvania (2380)
Puerto Rico (24)
Rhode Island (50)
South America (1187)
South Carolina (68)
South Dakota (1)
Southern California (4632)
Tennessee (182)
Texas (1831)
United States (42321)
Utah (359)
Vermont (1)
Virginia (279)
Washington D.C. (84)
Washington State (982)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
756,050 Results for "barrier therapeutics inc acquired by stiefel laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
February 5, 2026
·
3 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
November 17, 2025
·
17 min read
Neuroscience
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central nervous system.
November 3, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson’s Disease
January 29, 2026
·
5 min read
Press Releases
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
February 25, 2026
·
3 min read
Regulatory
Atara Climbs Amid Report of FDA Inconsistency Leading to Cell Therapy’s Rejection
The rejection of Atara Biotherapeutics’ Ebvallo in January was a “complete reversal” of the conesensus FDA reviewers had come to, according to a former agency employee, who said manufacturing problems were the only approvability barrier for the drug.
February 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Lilly to acquire Orna Therapeutics to advance cell therapies
February 9, 2026
·
5 min read
Press Releases
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
November 14, 2025
·
14 min read
1 of 75,605
Next
